Personalized medicine in cardiology: the time for genotype-guided therapy is now

被引：0
|
作者：
Cavallari, Larisa H. [1 ]
Nutescu, Edith A. [1 ]
Duarte, Julio D. [1 ]
机构：
[1] Univ Illinois, Dept Pharm Practice, 833 South Wood St,Room 164, Chicago, IL 60612 USA
来源：
FUTURE CARDIOLOGY | 2013年 / 9卷 / 04期
关键词：
genotype; personalized medicine; pharmacogenetics; polymorphism; warfarin;
D O I：
10.2217/FCA.13.35
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：459 / 464
页数：6
相关论文
共 50 条
  • [21] Genotype-guided warfarin therapy: Still of only questionable value two decades on
    Shah, Rashmi R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (03) : 547 - 560
  • [22] A Randomized Trial of Genotype-Guided Dosing of Warfarin
    Pirmohamed, Munir
    Burnside, Girvan
    Eriksson, Niclas
    Jorgensen, Andrea L.
    Toh, Cheng Hock
    Nicholson, Toby
    Kesteven, Patrick
    Christersson, Christina
    Wahlstrom, Bengt
    Stafberg, Christina
    Zhang, J. Eunice
    Leathart, Julian B.
    Kohnke, Hugo
    Maitland-van der Zee, Anke H.
    Williamson, Paula R.
    Daly, Ann K.
    Avery, Peter
    Kamali, Farhad
    Wadelius, Mia
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24) : 2294 - 2303
  • [23] Genotype-Guided Dosing of Vitamin K Antagonists
    Koller, Elizabeth A.
    Roche, Jeffrey C.
    Rollins, James A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (18) : 1761 - 1761
  • [24] A randomized trial of genotype-guided perindopril use
    Lee, Sang-Hak
    Lee, Chan Joo
    Kang, Yura
    Park, Jung Mi
    Lee, Ji Hyun
    JOURNAL OF HYPERTENSION, 2023, 41 (11) : 1768 - 1774
  • [25] Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials
    Tang, Tao
    Liu, Jie
    Zuo, Keqiang
    Cheng, Jie
    Chen, Linyin
    Lu, Chenhui
    Han, Shilong
    Xu, Jichong
    Jia, Zhongzhi
    Ye, Meng
    Pei, Erli
    Zhang, Xiaoping
    Li, Maoquan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20 (04) : 387 - 394
  • [26] Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
    Empey, Philip E.
    Stevenson, James M.
    Tuteja, Sony
    Weitzel, Kristin W.
    Angiolillo, Dominick J.
    Beitelshees, Amber L.
    Coons, James C.
    Duarte, Julio D.
    Franchi, Francesco
    Jeng, Linda J. B.
    Johnson, Julie A.
    Kreutz, Rolf P.
    Limdi, Nita A.
    Maloney, Kristin A.
    Obeng, Aniwaa Owusu
    Peterson, Josh F.
    Petry, Natasha
    Pratt, Victoria M.
    Rollini, Fabiana
    Scott, Stuart A.
    Skaar, Todd C.
    Vesely, Mark R.
    Stouffer, George A.
    Wilke, Russell A.
    Cavallari, Larisa H.
    Lee, Craig R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 664 - 674
  • [27] Early evaluation of a novel alert within cardiac procedural areas to facilitate genotype-guided antiplatelet therapy
    Van Heukelom, Joel
    Weaver, Max
    Max, Carson
    Baye, Jordan F.
    Peterson, Ashley
    Maryniak, Andrii
    Stys, Tomsaz P.
    Massmann, Amanda
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (08): : 754 - 762
  • [28] Genotype-guided dietary supplementation in precision nutrition
    Gkouskou, Kalliopi K.
    Grammatikopoulou, Maria G.
    Vlastos, Ioannis
    Sanoudou, Despina
    Eliopoulos, Aristides G.
    NUTRITION REVIEWS, 2021, 79 (11) : 1225 - 1235
  • [29] Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin
    Dahal, Khagendra
    Sharma, Sharan P.
    Fung, Erik
    Lee, Juyong
    Moore, Jason H.
    Unterborn, John N.
    Williams, Scott M.
    CHEST, 2015, 148 (03) : 701 - 710
  • [30] Personalized medicine and antiplatelet therapy: ready for prime time?
    Verstuyft, Celine
    Simon, Tabassome
    Kim, Richard B.
    EUROPEAN HEART JOURNAL, 2009, 30 (16) : 1943 - 1963
12345